Host restriction of murine gammaherpesvirus 68 replication by human APOBEC3 cytidine deaminases but not murine APOBEC3

Virology

Volumn 454-455, Issue 1, 2014, Pages 215-226

  Minkah, Nana ^a   Chavez, Kevin ^a   Shah, Parth ^b   MacCarthy, Thomas ^b   Chen, Hui ^c,d,e   Landau, Nathaniel ^c,d   Krug, Laurie T ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b Stony Brook University   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^d SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^e Department of Obstetrics Gynecology   (United States)

Author keywords

APOBEC3; Cytidine deaminase; Herpesvirus; Host restriction; Latency; Murine gammaherpesvirus; Pathogenesis; Replication

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE A3A; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE A3B; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE A3C; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE A3DE; CYTIDINE DEAMINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA VIRUS; GENE MUTATION; GENE SEQUENCE; HERPES VIRUS; HOST RESISTANCE; HUMAN; HUMAN CELL; IN VIVO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; RNA VIRUS; VIRION; VIRUS GENE; VIRUS REPLICATION; VIRUS STRAIN;

APOBEC3; CYTIDINE DEAMINASE; HERPESVIRUS; HOST RESTRICTION; LATENCY; MURINE GAMMAHERPESVIRUS; PATHOGENESIS; REPLICATION;

ANIMALS; CELL LINE; CYTIDINE DEAMINASE; CYTOSINE DEAMINASE; HUMANS; MICE; MICE, KNOCKOUT; RHADINOVIRUS; VIRAL TROPISM;

EID: 84896008417     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2014.02.022     Document Type: Article

References (75)

1. Bishop K.N., Holmes R.K., Sheehy A.M., Malim M.H. APOBEC-mediated editing of viral RNA. Science 2004, 305:645.
2. Bogerd H.P., Tallmadge R.L., Oaks J.L., Carpenter S., Cullen B.R. Equine infectious anemia virus resists the antiretroviral activity of equine APOBEC3 proteins through a packaging-independent mechanism. J. Virol. 2008, 82:11889-11901.
3. Bogerd H.P., Wiegand H.L., Hulme A.E., Garcia-Perez J.L., O'Shea K.S., Moran J.V., Cullen B.R. Cellular inhibitors of long interspersed element 1 and Alu retrotransposition. Proc. Natl. Acad. Sci. USA 2006, 103:8780-8785.
4. Boutell C., Everett R.D. Regulation of alphaherpesvirus infections by the ICP0 family of proteins. J. Gen. Virol. 2013, 94:465-481.
5. Bransteitter R., Prochnow C., Chen X.S. The current structural and functional understanding of APOBEC deaminases. Cell. Mol. Life Sci. 2009, 66:3137-3147.
6. Chen H., Lilley C.E., Yu Q., Lee D.V., Chou J., Narvaiza I., Landau N.R., Weitzman M.D. APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons. Curr. Biol. 2006, 16:480-485.
7. Clambey E.T., Virgin H.W.t., Speck S.H. Disruption of the murine gammaherpesvirus 68 M1 open reading frame leads to enhanced reactivation from latency. J. Virol. 2000, 74:1973-1984.
8. Collins C.M., Speck S.H. Tracking murine gammaherpesvirus 68 infection of germinal center B cells in vivo. PloS One 2012, 7:e33230.
9. Cullen B.R. Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors. J. Virol. 2006, 80:1067-1076.
10. de Bruyn Kops A., Knipe D.M. Preexisting nuclear architecture defines the intranuclear location of herpesvirus DNA replication structures. J. Virol. 1994, 68:3512-3526.
11. Delebecque F., Suspene R., Calattini S., Casartelli N., Saib A., Froment A., Wain-Hobson S., Gessain A., Vartanian J.P., Schwartz O. Restriction of foamy viruses by APOBEC cytidine deaminases. J. Virol. 2006, 80:605-614.
12. Doehle B.P., Schafer A., Wiegand H.L., Bogerd H.P., Cullen B.R. Differential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion. J. Virol. 2005, 79:8201-8207.
13. Driscoll D.M., Zhang Q. Expression and characterization of p27, the catalytic subunit of the apolipoprotein B mRNA editing enzyme. J. Biol. Chem. 1994, 269:19843-19847.
14. Full F., Reuter N., Zielke K., Stamminger T., Ensser A. Herpesvirus saimiri antagonizes nuclear domain 10-instituted intrinsic immunity via an ORF3-mediated selective degradation of cellular protein Sp100. J. Virol. 2012, 86:3541-3553.
15. Gee P., Ando Y., Kitayama H., Yamamoto S.P., Kanemura Y., Ebina H., Kawaguchi Y., Koyanagi Y. APOBEC1-mediated editing and attenuation of herpes simplex virus 1 DNA indicate that neurons have an antiviral role during herpes simplex encephalitis. J. Virol. 2011, 85:9726-9736.
16. Goila-Gaur R., Strebel K. HIV-1 Vif, APOBEC, and intrinsic immunity. Retrovirology 2008, 5:51.
17. Hakata Y., Landau N.R. Reversed functional organization of mouse and human APOBEC3 cytidine deaminase domains. J. Biol. Chem. 2006, 281:36624-36631.
18. Hultquist J.F., Lengyel J.A., Refsland E.W., LaRue R.S., Lackey L., Brown W.L., Harris R.S. Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1. J. Virol. 2011, 85:11220-11234.
19. Jacoby M.A., Virgin H.W.t., Speck S.H. Disruption of the M2 gene of murine gammaherpesvirus 68 alters splenic latency following intranasal, but not intraperitoneal, inoculation. J. Virol. 2002, 76:1790-1801.
20. Jern P., Russell R.A., Pathak V.K., Coffin J.M. Likely role of APOBEC3G-mediated G-to-A mutations in HIV-1 evolution and drug resistance. PLoS Pathog. 2009, 5:e1000367.
21. Kinomoto M., Kanno T., Shimura M., Ishizaka Y., Kojima A., Kurata T., Sata T., Tokunaga K. All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition. Nucl. Acids Res. 2007, 35:2955-2964.
22. Kitamura K., Wang Z., Chowdhury S., Simadu M., Koura M., Muramatsu M. Uracil DNA glycosylase counteracts APOBEC3G-induced hypermutation of hepatitis B viral genomes: excision repair of covalently closed circular DNA. PLoS Pathog. 2013, 9:e1003361.
23. Lackey L., Demorest Z.L., Land A.M., Hultquist J.F., Brown W.L., Harris R.S. APOBEC3B and AID have similar nuclear import mechanisms. J. Mol. Biol. 2012, 419:301-314.
24. Langlois M.A., Kemmerich K., Rada C., Neuberger M.S. The AKV murine leukemia virus is restricted and hypermutated by mouse APOBEC3. J. Virol. 2009, 83:11550-11559.
25. Li M.M., Emerman M. Polymorphism in human APOBEC3H affects a phenotype dominant for subcellular localization and antiviral activity. J. Virol. 2011, 85:8197-8207.
26. Liddament M.T., Brown W.L., Schumacher A.J., Harris R.S. APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo. Curr. Biol. 2004, 14:1385-1391.
27. Ling P.D., Tan J., Sewatanon J., Peng R. Murine gammaherpesvirus 68 open reading frame 75c tegument protein induces the degradation of PML and is essential for production of infectious virus. J. Virol. 2008, 82:8000-8012.
28. Low A., Okeoma C.M., Lovsin N., de las Heras M., Taylor T.H., Peterlin B.M., Ross S.R., Fan H. Enhanced replication and pathogenesis of Moloney murine leukemia virus in mice defective in the murine APOBEC3 gene. Virology 2009, 385:455-463.
29. MacMillan A.L., Kohli R.M., Ross S.R. APOBEC3 inhibition of mouse mammary tumor virus infection: the role of cytidine deamination versus inhibition of reverse transcription. J. Virol. 2013, 87:4808-4817.
30. Madsen P., Anant S., Rasmussen H.H., Gromov P., Vorum H., Dumanski J.P., Tommerup N., Collins J.E., Wright C.L., Dunham I., MacGinnitie A.J., Davidson N.O., Celis J.E. Psoriasis upregulated phorbolin-1 shares structural but not functional similarity to the mRNA-editing protein apobec-1. J Invest. Dermatol 1999, 113:162-169.
31. Mahieux R., Suspene R., Delebecque F., Henry M., Schwartz O., Wain-Hobson S., Vartanian J.P. Extensive editing of a small fraction of human T-cell leukemia virus type 1 genomes by four APOBEC3 cytidine deaminases. J. Gen. Virol. 2005, 86:2489-2494.
32. Malim M.H. APOBEC proteins and intrinsic resistance to HIV-1 infection. Philos. Trans. R. Soc. Lond. Ser. B: Biol. Sci. 2009, 364:675-687.
33. Malim M.H., Emerman M. HIV-1 accessory proteins--ensuring viral survival in a hostile environment. Cell Host Microbe 2008, 3:388-398.
34. Mangeat B., Turelli P., Caron G., Friedli M., Perrin L., Trono D. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 2003, 424:99-103.
35. Mariani R., Chen D., Schrofelbauer B., Navarro F., Konig R., Bollman B., Munk C., Nymark-McMahon H., Landau N.R. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 2003, 114:21-31.
36. Mehta A., Driscoll D.M. A sequence-specific RNA-binding protein complements apobec-1 To edit apolipoprotein B mRNA. Mol. Cell. Biol. 1998, 18:4426-4432.
37. Mikl M.C., Watt I.N., Lu M., Reik W., Davies S.L., Neuberger M.S., Rada C. Mice deficient in APOBEC2 and APOBEC3. Mol. Cell. Biol. 2005, 25:7270-7277.
38. Munk C., Beck T., Zielonka J., Hotz-Wagenblatt A., Chareza S., Battenberg M., Thielebein J., Cichutek K., Bravo I.G., O'Brien S.J., Lochelt M., Yuhki N. Functions, structure, and read-through alternative splicing of feline APOBEC3 genes. Genome Biol. 2008, 9:R48.
39. Narvaiza I., Linfesty D.C., Greener B.N., Hakata Y., Pintel D.J., Logue E., Landau N.R., Weitzman M.D. Deaminase-independent inhibition of parvoviruses by the APOBEC3A cytidine deaminase. PLoS Pathog. 2009, 5:e1000439.
40. OhAinle M., Kerns J.A., Malik H.S., Emerman M. Adaptive evolution and antiviral activity of the conserved mammalian cytidine deaminase APOBEC3H. J. Virol. 2006, 80:3853-3862.
41. Okeoma C.M., Lovsin N., Peterlin B.M., Ross S.R. APOBEC3 inhibits mouse mammary tumour virus replication in vivo. Nature 2007, 445:927-930.
42. Okuyama S., Marusawa H., Matsumoto T., Ueda Y., Matsumoto Y., Endo Y., Takai A., Chiba T. Excessive activity of apolipoprotein B mRNA editing enzyme catalytic polypeptide 2 (APOBEC2) contributes to liver and lung tumorigenesis. J. Int. Cancer 2012, 130:1294-1301.
43. Penkert R.R., Kalejta R.F. Tale of a tegument transactivator: the past, present and future of human CMV pp71. Future virol. 2012, 7:855-869.
44. Petit V., Guetard D., Renard M., Keriel A., Sitbon M., Wain-Hobson S., Vartanian J.P. Murine APOBEC1 is a powerful mutator of retroviral and cellular RNA in vitro and in vivo. J. Mol. Biol. 2009, 385:65-78.
45. Quinlan M.P., Chen L.B., Knipe D.M. The intranuclear location of a herpes simplex virus DNA-binding protein is determined by the status of viral DNA replication. Cell 1984, 36:857-868.
46. Refsland E.W., Harris R.S. The APOBEC3 family of retroelement restriction factors. Curr. Top. Microbiol. Immunol. 2013, 371:1-27.
47. Renard M., Henry M., Guetard D., Vartanian J.P., Wain-Hobson S. APOBEC1 and APOBEC3 cytidine deaminases as restriction factors for hepadnaviral genomes in non-humans in vivo. J. Mol. Biol. 2010, 400:323-334.
48. Saffert R.T., Kalejta R.F. Promyelocytic leukemia-nuclear body proteins: herpesvirus enemies, accomplices, or both?. Future Virol. 2008, 3:265-277.
49. Sanchez-Martinez S., Aloia A.L., Harvin D., Mirro J., Gorelick R.J., Jern P., Coffin J.M., Rein A. Studies on the restriction of murine leukemia viruses by mouse APOBEC3. PloS One 2012, 7:e38190.
50. Sathish N., Yuan Y. Evasion and subversion of interferon-mediated antiviral immunity by Kaposi[U+05F3]s sarcoma-associated herpesvirus: an overview. J. Virol. 2011, 85:10934-10944.
51. Senavirathne G., Jaszczur M., Auerbach P.A., Upton T.G., Chelico L., Goodman M.F., Rueda D. Single-stranded DNA scanning and deamination by APOBEC3G cytidine deaminase at single molecule resolution. J. Biol. Chem. 2012, 287:15826-15835.
52. Sewatanon J., Ling P.D. Murine gammaherpesvirus 68 ORF75c contains ubiquitin E3 ligase activity and requires PML SUMOylation but not other known cellular PML regulators, CK2 and E6AP, to mediate PML degradation. Virology 2013, 440:140-149.
53. Sewatanon J., Liu H., Ling P.D. PML protein modulates establishment and maintenance of latent gamma-herpesvirus infection in peritoneal cells. J. Virol. 2013.
54. Sheehy A.M., Gaddis N.C., Choi J.D., Malim M.H. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 2002, 418:646-650.
55. Smith H.C., Bennett R.P., Kizilyer A., McDougall W.M., Prohaska K.M. Functions and regulation of the APOBEC family of proteins. Semin. Cell. Dev. Biol. 2012, 23:258-268.
56. Stavrou S., Nitta T., Kotla S., Ha D., Nagashima K., Rein A.R., Fan H., Ross S.R. Murine leukemia virus glycosylated Gag blocks apolipoprotein B editing complex 3 and cytosolic sensor access to the reverse transcription complex. Proc. Natl. Acad. Sci. USA 2013, 110:9078-9083.
57. Stenglein M.D., Burns M.B., Li M., Lengyel J., Harris R.S. APOBEC3 proteins mediate the clearance of foreign DNA from human cells. Nat. Struct. Mol. Biol. 2010, 17:222-229.
58. Suspene R., Aynaud M.M., Koch S., Pasdeloup D., Labetoulle M., Gaertner B., Vartanian J.P., Meyerhans A., Wain-Hobson S. Genetic editing of herpes simplex virus 1 and Epstein-Barr herpesvirus genomes by human APOBEC3 cytidine deaminases in culture and in vivo. J. Virol. 2011, 85:7594-7602.
59. Suspene R., Guetard D., Henry M., Sommer P., Wain-Hobson S., Vartanian J.P. Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo. Proc. Natl. Acad. Sci. USA 2005, 102:8321-8326.
60. Suspene R., Henry M., Guillot S., Wain-Hobson S., Vartanian J.P. Recovery of APOBEC3-edited human immunodeficiency virus G->A hypermutants by differential DNA denaturation PCR. J. Gen. Virol. 2005, 86:125-129.
61. Suspene R., Sommer P., Henry M., Ferris S., Guetard D., Pochet S., Chester A., Navaratnam N., Wain-Hobson S., Vartanian J.P. APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase. Nucl. Acids Res. 2004, 32:2421-2429.
62. Takeda E., Tsuji-Kawahara S., Sakamoto M., Langlois M.A., Neuberger M.S., Rada C., Miyazawa M. Mouse APOBEC3 restricts friend leukemia virus infection and pathogenesis in vivo. J. Virol. 2008, 82:10998-11008.
63. Taylor B.J., Nik-Zainal S., Wu Y.L., Stebbings L.A., Raine K., Campbell P.J., Rada C., Stratton M.R., Neuberger M.S. DNA deaminases induce break-associated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis. eLife 2013, 2:e00534.
64. Trivedi N.R., Gilliland K.L., Zhao W., Liu W., Thiboutot D.M. Gene array expression profiling in acne lesions reveals marked upregulation of genes involved in inflammation and matrix remodeling. J. Invest. Dermatol. 2006, 126:1071-1079.
65. Tsai K., Thikmyanova N., Wojcechowskyj J.A., Delecluse H.J., Lieberman P.M. EBV tegument protein BNRF1 disrupts DAXX-ATRX to activate viral early gene transcription. PLoS Pathog. 2011, 7:e1002376.
66. Vartanian J.P., Guetard D., Henry M., Wain-Hobson S. Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions. Science 2008, 320:230-233.
67. Weck K.E., Barkon M.L., Yoo L.I., Speck S.H., Virgin H.I. Mature B cells are required for acute splenic infection, but not for establishment of latency, by murine gammaherpesvirus 68. J. Virol. 1996, 70:6775-6780.
68. Weck K.E., Kim S.S., Virgin H.I., Speck S.H. B cells regulate murine gammaherpesvirus 68 latency. J. Virol. 1999, 73:4651-4661.
69. Weck K.E., Kim S.S., Virgin H.I., Speck S.H. Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells. J. Virol. 1999, 73:3273-3283.
70. Weller S.K. Herpes simplex virus reorganizes the cellular DNA repair and protein quality control machinery. PLoS Pathog. 2010, 6:e1001105.
71. Yu Q., Chen D., Konig R., Mariani R., Unutmaz D., Landau N.R. APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication. J. Biol. Chem. 2004, 279:53379-53386.
72. Zerboni L., Sen N., Oliver S.J., Arvin A.M. Molecular mechanisms of varicella zoster virus pathogenesis. Nat. Rev. Microbiol. 2014, 12:197-210.
73. Zhang H., Yang B., Pomerantz R.J., Zhang C., Arunachalam S.C., Gao L. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 2003, 424:94-98.
74. Zheng Y.H., Irwin D., Kurosu T., Tokunaga K., Sata T., Peterlin B.M. Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication. J. Virol. 2004, 78:6073-6076.
75. Zhu F.X., King S.M., Smith E.J., Levy D.E., Yuan Y. A Kaposi[U+05F3]s sarcoma-associated herpesviral protein inhibits virus-mediated induction of type I interferon by blocking IRF-7 phosphorylation and nuclear accumulation. Proc. Natl. Acad. Sci. USA. 2002, 99:5573-5578.